Answers are grounded in this paper and cite their sources.
Randomized trial demonstrates reduced proteinuria in IgA nephropathy patients with supportive care, suggesting treatment benefits.
= 0.01). No significant differences in estimated glomerular filtration rate or adverse event rates were observed between groups. Yi-Shen-Hua-Shi granule, added to best supportive care, safely produced a greater short-term reduction in proteinuria, particularly in patients with high baseline proteinuria.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: